The purpose of the study is to investigate the routes of elimination and overall mass balance of 100 mg quemliclustat containing 75 μCi \[14C\] following a single IV infusion of \[14C\]-quemliclustat in healthy adult male participants, and to quantify total radioactivity (TRA) in plasma, whole blood, urine, and feces.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of total radioactivity excreted in urine and feces
Timeframe: Up to 40 days
Total radioactivity in blood
Timeframe: Up to 40 days
Total radioactivity in plasma
Timeframe: Up to 40 days
Excretion of total radioactivity in urine
Timeframe: Up to 40 days
Excretion of total radioactivity in feces
Timeframe: Up to 40 days